Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Debt to Equity (2017)

Historic Debt to Equity for Aclaris Therapeutics (ACRS) over the last 1 years, with Q4 2017 value amounting to $0.0.

  • Aclaris Therapeutics' Debt to Equity changed N/A to $0.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2017, which is N/A changed from last year.
  • As of Q4 2017, Aclaris Therapeutics' Debt to Equity stood at $0.0.
  • Aclaris Therapeutics' 5-year Debt to Equity high stood at $0.0 for Q4 2017, and its period low was $0.0 during Q4 2017.